<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20423" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Dexamethasone Suppression Test</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dogra</surname>
            <given-names>Prerna</given-names>
          </name>
          <aff>University of Kentucky</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vijayashankar</surname>
            <given-names>Narasimha P.</given-names>
          </name>
          <aff>Xavier University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prerna Dogra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Narasimha Vijayashankar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20423.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The dexamethasone suppression test&#x000a0;is used&#x000a0;to diagnose endogenous Cushing syndrome by assessing the lack of suppression of the hypothalamic-pituitary-adrenal axis in response to exogenous corticosteroids.<xref ref-type="bibr" rid="article-20423.r1">[1]</xref>&#x000a0;The first use of dexamethasone for diagnosing&#x000a0;Cushing syndrome was in 1960 by Liddle; he developed a test based on the non-suppressibility of endogenous cortisol production in Cushing syndrome versus the physiological suppression in nonaffected individuals achieved by dexamethasone.<xref ref-type="bibr" rid="article-20423.r2">[2]</xref></p>
        <p>Dexamethasone is a potent synthetic corticosteroid (dexamethasone&#x000a0;0.75 mg= prednisone;&#x000a0;5 mg= methylprednisolone; 4 mg= hydrocortisone 20 mg) with high affinity for glucocorticoid receptors and a long duration of action (biological half-life 36-54 hours; plasma half-life 4-5 hours).<xref ref-type="bibr" rid="article-20423.r3">[3]</xref>&#x000a0;Furthermore,&#x000a0;dexamethasone possesses minimal mineralocorticoid activity, and unlike other glucocorticoids, this corticosteroid&#x000a0;does not interfere with cortisol measurement in the plasma, urine, or saliva.&#x000a0;These qualities make dexamethasone the preferred steroid for assessing the hypothalamic-pituitary-adrenal axis.<xref ref-type="bibr" rid="article-20423.r4">[4]</xref></p>
        <p>The dexamethasone suppression test&#x000a0;is also used&#x000a0;to investigate mild autonomous cortisol excess in patients with incidentalomas. (See&#x000a0;<bold>Image.</bold>&#x000a0;Dexamethasone Suppression Test.) For diagnosing Cushing syndrome and mild autonomous cortisol excess, a serum cortisol concentration of 1.8&#x02009;&#x000b5;g/dL (50&#x02009;nmol/L) is the widely recommended cut-off point that increases the diagnostic sensitivity of the test to approximately 95%.<xref ref-type="bibr" rid="article-20423.r5">[5]</xref>&#x000a0;Serum cortisol concentrations less than 1.8&#x02009;&#x000b5;g/dL suggest adequate hypothalamic-pituitary-adrenal axis suppression after&#x000a0;dexamethasone administration,&#x000a0;effectively excluding Cushing syndrome.<xref ref-type="bibr" rid="article-20423.r6">[6]</xref></p>
        <p>Inappropriately low serum dexamethasone levels during the 1-mg dexamethasone suppression test may result in false-positive results. This phenomenon is associated with recurrent use of cytochrome P450 3A4 (CYP3A4)-inducing drugs or gastrointestinal abnormalities. When serum dexamethasone is undetectable, the primary reason is failure to take the medication appropriately. Chronic use of glucocorticoids can also lead to low dexamethasone levels because exogenous glucocorticoids suppress cortisol and the cortisol receptors, which also bind dexamethasone; this lack of available receptors can cause dexamethasone to&#x000a0;be excreted&#x000a0;without physiological action.<xref ref-type="bibr" rid="article-20423.r7">[7]</xref>&#x000a0;Simultaneous measurement of serum cortisol and dexamethasone allows for dexamethasone suppression test validation, improving accuracy and avoiding unnecessary repetitions. Adherence to verbal or written recommendations is critical for interpreting the test. The measured dexamethasone level should be higher than 200 ng/dL (4.5 nmol/L) for an accurate result.</p>
      </sec>
      <sec id="article-20423.s2" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The hypothalamic-pituitary-adrenal axis, a primary neuroendocrine system, helps&#x000a0;maintain homeostatic&#x000a0;function and the stress response.<xref ref-type="bibr" rid="article-20423.r8">[8]</xref>&#x000a0;Neurons in the paraventricular nucleus of the hypothalamus synthesize corticotropin-releasing hormone, which&#x000a0;is transported&#x000a0;through the hypophyseal portal blood to the anterior pituitary, which stimulates adrenocorticotropic hormone production.<xref ref-type="bibr" rid="article-20423.r9">[9]</xref>&#x000a0;Adrenocorticotropic hormone is transported through the systemic vasculature to the adrenal glands and stimulates the synthesis and secretion of cortisol by zona&#x000a0;fasciculata&#x000a0;of the adrenal cortex.<xref ref-type="bibr" rid="article-20423.r10">[10]</xref></p>
        <p>Under basal conditions, only about 5% to 10% of circulating cortisol is free.<xref ref-type="bibr" rid="article-20423.r11">[11]</xref>&#x000a0;The rest is bound to proteins, with approximately 85% binding to transcortin (cortisol-binding globulin) and 5% to 10% binding to albumin. Although the free fraction is physiologically active, the albumin-bound fraction is also available due to the low binding affinity of albumin for cortisol.<xref ref-type="bibr" rid="article-20423.r12">[12]</xref>&#x000a0;Unbound cortisol is filtered at the glomerulus and&#x000a0;is subsequently excreted. This fraction constitutes less than 1% of the total cortisol synthesized daily; the rest&#x000a0;is excreted&#x000a0;as soluble metabolites and glucuronide conjugates.<xref ref-type="bibr" rid="article-20423.r13">[13]</xref>&#x000a0;The excretory products of cortisol that contain the dihydroxyacetone group are known as 17-hydroxycorticosteroids.<xref ref-type="bibr" rid="article-20423.r14">[14]</xref>&#x000a0;Urinary 17-hydroxycorticosteroid&#x000a0;was previously used&#x000a0;as an indirect measure of cortisol secretion rate. Urinary cortisol reflects free, circulating cortisol levels in the blood.<xref ref-type="bibr" rid="article-20423.r15">[15]</xref></p>
        <p>Serum cortisol, also called the stress hormone, exerts negative feedback on both the hypothalamus and the anterior pituitary, inhibiting the secretion of corticotropin-releasing hormone and adrenocorticotropic hormone, respectively. This positive&#x000a0;or negative feedback mechanism helps regulate serum cortisol levels and the stress response.<xref ref-type="bibr" rid="article-20423.r16">[16]</xref>&#x000a0;When the hypothalamic-pituitary-adrenal axis is intact, exogenously administered corticosteroids exert feedback inhibition on serum corticotropin-releasing hormone and adrenocorticotropic hormone production by binding to the hypothalamic and pituitary glucocorticoid receptors, respectively, which subsequently leads to the suppression of serum cortisol synthesis and secretion.<xref ref-type="bibr" rid="article-20423.r8">[8]</xref>&#x000a0;However, in pathological hypercortisolism, the hypothalamic-pituitary-adrenal axis becomes partially or entirely resistant to feedback inhibition by exogenous steroids.<xref ref-type="bibr" rid="article-20423.r17">[17]</xref></p>
      </sec>
      <sec id="article-20423.s3" sec-type="Specimen Requirements and Procedure">
        <title>Specimen Requirements and Procedure</title>
        <p>Both serum and heparinized plasma are suitable specimens for measuring cortisol in the blood.<xref ref-type="bibr" rid="article-20423.r18">[18]</xref>&#x000a0;Specimens can be stored at&#x000a0;2&#x000a0;&#x000b0;C to 8 &#x000b0;C for&#x000a0;2&#x000a0;days. For more extended storage, specimens must&#x000a0;be frozen. Freeze-thaw cycles have not&#x000a0;been found&#x000a0;to alter cortisol concentrations significantly.<xref ref-type="bibr" rid="article-20423.r19">[19]</xref>&#x000a0;Immunoassays are the main methods for estimating cortisol in clinical laboratories. These immunoassays are competitive immunoassays, where cortisol in the sample competes with labeled cortisol for a&#x000a0;limited number of anti-cortisol antibodies.<xref ref-type="bibr" rid="article-20423.r20">[20]</xref>&#x000a0;Many commercial kits are available for the determination of plasma and urinary cortisol. Many immunoassays are now automated and available on semi-automated or automated analyzer platforms.<xref ref-type="bibr" rid="article-20423.r21">[21]</xref>&#x000a0;These immunoassays can be either heterogeneous assays, where a separation step is required to distinguish the bound from unbound fractions, or homogenous assays, where no separation is required.<xref ref-type="bibr" rid="article-20423.r22">[22]</xref>&#x000a0;The specificity of immunoassays depends mainly on the properties of the antibody.<xref ref-type="bibr" rid="article-20423.r23">[23]</xref></p>
        <p>Chromatographic methods are an alternative to immunoassay for the determination of cortisol. These methods have the advantage of less interference&#x000a0;but are&#x000a0;time-consuming and unsuitable for routine analysis.<xref ref-type="bibr" rid="article-20423.r24">[24]</xref>&#x000a0;Among&#x000a0;the chromatographic techniques, clinical laboratories often use high-performance liquid chromatography.<xref ref-type="bibr" rid="article-20423.r25">[25]</xref>&#x000a0;All high-performance liquid chromatography methods require either liquid-liquid or solid-phase extraction columns to extract cortisol from the sample. Both reversed-phase and normal-phase columns&#x000a0;are used&#x000a0;for chromatographic analyses, and the column effluents&#x000a0;are monitored&#x000a0;by either ultraviolet (254 nm) or fluorescence spectroscopy.<xref ref-type="bibr" rid="article-20423.r26">[26]</xref></p>
      </sec>
      <sec id="article-20423.s4" sec-type="Testing Procedures">
        <title>Testing Procedures</title>
        <p>
<bold>Types of Dexamethasone Suppression Tests</bold>
</p>
        <p>There are&#x000a0;4&#x000a0;different types of dexamethasone suppression tests.&#x000a0;</p>
        <p><bold>Low-dose dexamethasone suppression test:&#x000a0;</bold>This&#x000a0;test in&#x000a0;the initial diagnosis of Cushing syndrome&#x000a0;as&#x000a0;either a screening or a confirmatory test.<xref ref-type="bibr" rid="article-20423.r27">[27]</xref>&#x000a0;The test can be performed in 2 different formats&#x02014;overnight or as a 2-day test.</p>
        <list list-type="bullet">
          <list-item>
            <p>Overnight, 1 mg test: The overnight test is the most commonly used screening test due to ease and convenience. Dexamethasone 1 mg is administered orally between 11 PM and midnight. Serum cortisol levels are drawn between 8&#x000a0;AM and 9 AM the&#x000a0;next morning.<xref ref-type="bibr" rid="article-20423.r28">[28]</xref><xref ref-type="bibr" rid="article-20423.r29">[29]</xref></p>
          </list-item>
          <list-item>
            <p>Two-day, 2 mg test: Dexamethasone 0.5 mg is administered orally every 6 hours, typically at 9 AM, 3 PM, 9 PM, and 3 AM, for&#x000a0;2&#x000a0;days,&#x000a0;resulting in a total dose of 4 mg. Serum cortisol levels are drawn 6 hours,&#x000a0;typically at 9 AM, after the last administered dose.<xref ref-type="bibr" rid="article-20423.r2">[2]</xref></p>
          </list-item>
        </list>
        <p><bold>High-dose dexamethasone suppression test:&#x000a0;</bold>Once the diagnosis of Cushing syndrome is confirmed, the next step is to categorize adrenocorticotropic&#x000a0;hormone&#x02013;independent&#x000a0;versus adrenocorticotropic&#x000a0;hormone&#x02013;dependent&#x000a0;Cushing syndrome by checking the plasma adrenocorticotropic hormone levels. In adrenocorticotropic&#x000a0;hormone&#x02013;independent&#x000a0;Cushing syndrome, the plasma adrenocorticotropic hormone is low or undetectable, indicating an adrenal etiology (causing pituitary suppression of adrenocorticotropic hormone).&#x000a0;In adrenocorticotropic&#x000a0;hormone&#x02013;dependent&#x000a0;Cushing syndrome, plasma adrenocorticotropic hormone is inappropriately normal or high, suggesting either a pituitary or an ectopic source.</p>
        <p>In adrenocorticotropic&#x000a0;hormone&#x02013;dependent&#x000a0;Cushing syndrome, the high-dose&#x000a0;dexamethasone&#x000a0;suppression&#x000a0;test can help distinguish a pituitary&#x000a0;source, that is, Cushing disease)&#x000a0;from an ectopic source of adrenocorticotropic hormone overproduction.&#x000a0;The principle behind the high-dose&#x000a0;dexamethasone&#x000a0;suppression&#x000a0;test is that the overproduction of adrenocorticotropic hormone observed in Cushing disease, but not ectopic tumors, can undergo either partial or complete suppression by high doses of dexamethasone (approximately 8 mg). Like the low-dose&#x000a0;dexamethasone&#x000a0;suppression&#x000a0;test, the high-dose&#x000a0;dexamethasone&#x000a0;suppression&#x000a0;test utilizes oral dexamethasone&#x000a0;as either an overnight or 2-day test.</p>
        <list list-type="bullet">
          <list-item>
            <p>Overnight, 8&#x000a0;mg test: Baseline morning serum cortisol is measured, and oral dexamethasone 8 mg&#x000a0;is administered&#x000a0;between 11 PM and midnight. Repeat serum cortisol levels&#x000a0;are&#x000a0;drawn the following morning, typically between 8 AM and 9 AM.<xref ref-type="bibr" rid="article-20423.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>Two-day, 8 mg test: On day 1, baseline morning serum cortisol or 24-hour urinary-free cortisol from the previous day&#x000a0;is obtained. Dexamethasone 2 mg is administered orally every 6 hours,&#x000a0;typically at 9 AM, 3 PM, 9 PM, and 3 AM, for&#x000a0;2&#x000a0;days to complete a total dose of 16 mg over days 1 and 2. A&#x000a0;urine sample for urinary-free cortisol is collected simultaneously with dexamethasone administration. In addition, serum cortisol levels are checked 6 hours after the last dose of dexamethasone, typically at 9 AM on day 2.<xref ref-type="bibr" rid="article-20423.r2">[2]</xref></p>
          </list-item>
        </list>
        <p><bold>Intravenous dexamethasone suppression test:&#x000a0;</bold>This test helps in the initial diagnosis of Cushing syndrome while overcoming concerns of drug compliance and malabsorption.<xref ref-type="bibr" rid="article-20423.r31">[31]</xref>&#x000a0;In addition,&#x000a0;it is useful&#x000a0;when differentiating Cushing disease from adrenocorticotropic&#x000a0;hormone&#x02013;dependent&#x000a0;ectopic tumors and adrenocorticotropic&#x000a0;hormone&#x02013;independent&#x000a0;adrenal etiologies.<xref ref-type="bibr" rid="article-20423.r32">[32]</xref>&#x000a0;After a baseline morning serum cortisol (between 8 AM and 9 AM)&#x000a0;is obtained, an infusion of intravenous dexamethasone at 1 mg/h for 4 to 7 hours&#x000a0;is administered. Repeat serum cortisol levels are measured at the end of the infusion (day 1) and 23 to 24 hours later (day 2).<xref ref-type="bibr" rid="article-20423.r33">[33]</xref></p>
        <p><bold>Dexamethasone suppressed corticotropin-releasing hormone test:&#x000a0;</bold>Based on the rationale that glucocorticoid suppression of the hypothalamic-pituitary-adrenal axis can&#x000a0;be overcome&#x000a0;by&#x000a0;corticotropin-releasing hormone stimulation in Cushing disease and not in pseudo-Cushing syndrome, also known as physiological hypercortisolism, this test helps distinguish the two entities. Dexamethasone 0.5 mg every 6 hours, typically at 12 PM, 6 PM, 12 AM, and 6 AM, is given orally for 48 hours. Two hours after the last dose of dexamethasone,&#x000a0;an intravenous corticotropin-releasing hormone dose of 1 mcg/kg is administered, typically at 8 AM, and serum cortisol levels&#x000a0;are drawn&#x000a0;15 minutes later.<xref ref-type="bibr" rid="article-20423.r34">[34]</xref></p>
      </sec>
      <sec id="article-20423.s5" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>Considerations&#x000a0;and factors relevant to the evaluation and diagnosis of hypercortisolemia and Cushing syndrome include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Iatrogenic hypercortisolism can&#x000a0;lead&#x000a0;to exogenous Cushing syndrome.<xref ref-type="bibr" rid="article-20423.r35">[35]</xref><xref ref-type="bibr" rid="article-20423.r36">[36]</xref>&#x000a0;Biochemical testing shows elevated serum cortisol levels&#x000a0;(due&#x000a0;to the cross-reactivity of most exogenous steroids with cortisol immunoassays)&#x000a0;and depressed&#x000a0;adrenocorticotropic hormone (ACTH) adrenocorticotropic hormone&#x000a0;levels, as is&#x000a0;typically&#x000a0;usually observed&#x000a0;in&#x000a0;ACTH-independent adrenocorticotropic&#x000a0;hormone-independent&#x000a0;Cushing syndrome.<xref ref-type="bibr" rid="article-20423.r37">[37]</xref><xref ref-type="bibr" rid="article-20423.r38">[38]</xref>&#x000a0;Individuals&#x000a0;receiving exogenous corticosteroids&#x02014;irrespective of the route of administration,&#x000a0;eg, inhaled, topical, parenteral,&#x000a0;intra-articular&#x02014;must&#x000a0;be identified before pursuing a work-up for&#x000a0;pathological&#x000a0;hypercortisolemia.<xref ref-type="bibr" rid="article-20423.r36">[36]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pseudo-Cushing syndrome, also called physiological or non-neoplastic hypercortisolism, is&#x000a0;seen in conditions&#x000a0;such&#x000a0;as&#x000a0;alcohol use disorder, obesity, insulin resistance, and neuropsychiatric disorders due to&#x000a0;HPA axis stimulation.<xref ref-type="bibr" rid="article-20423.r38">[38]</xref><xref ref-type="bibr" rid="article-20423.r39">[39]</xref>&#x000a0;Obtaining a detailed&#x000a0;history and&#x000a0;performing a thorough&#x000a0;physical examination are&#x000a0;pivotal in recognizing many&#x000a0;individuals&#x000a0;with pseudo-Cushing syndrome. In equivocal cases, midnight serum cortisol, late-night salivary cortisol, dexamethasone-corticotropin-releasing hormone, or desmopressin testing can assist in the distinction.<xref ref-type="bibr" rid="article-20423.r23">[23]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>In any acute&#x000a0;illness strain, whether&#x000a0;emotional or physical, a stress response can&#x000a0;occur&#x000a0;through stimulation of the&#x000a0;HPA axis, resulting in elevated&#x000a0;ACTH hormone&#x000a0;and cortisol levels.&#x000a0;Therefore, evaluation&#x000a0;for Cushing syndrome should take place after the resolution of acute stress.<xref ref-type="bibr" rid="article-20423.r40">[40]</xref><xref ref-type="bibr" rid="article-20423.r41">[41]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Corticosteroid-binding globulin: Approximately 90% of circulating cortisol is protein-bound in this globulin. &#x000a0;Available assays measure the total cortisol&#x000a0;levels&#x000a0;(free and protein-bound). However, certain&#x000a0;conditions resulting in elevated levels of circulating corticosteroid-binding globulin (CBG), such as pregnancy or use of estrogen-containing medications, or reduced levels of circulating&#x000a0;CBG, such as malnutrition or nephrotic syndrome, may lead to spurious results on&#x000a0;DST.<xref ref-type="bibr" rid="article-20423.r39">[39]</xref><xref ref-type="bibr" rid="article-20423.r42">[42]</xref>&#x000a0;Late-night salivary cortisol or&#x000a0;urinary-free cortisol (UFC)&#x000a0;is the preferred test in these situations. Patients receiving estrogen therapy should ideally stop treatment at least&#x000a0;&#x000a0;6&#x000a0;weeks before&#x000a0;the DST.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Dexamethasone bioavailability:&#x000a0;MalabsorptionDexamethasone bioavailability can be affected by factors such as malabsorption, altered metabolism, or&#x000a0;non-compliance&#x000a0;with&#x000a0;taking the&#x000a0;medication&#x000a0;can result in variable bioavailability of dexamethasone,&#x000a0;confounding&#x000a0;the&#x000a0;variable results.&#x000a0;The liver metabolizes dexamethasone&#x000a0;through&#x000a0;CYP3A4.<xref ref-type="bibr" rid="article-20423.r41">[41]</xref><xref ref-type="bibr" rid="article-20423.r43">[43]</xref>&#x000a0;Thus, CYP3A4 inducers&#x000a0;such as phenytoin and&#x000a0;carbamazepine&#x000a0;or CYP3A4 inhibitors&#x000a0;(such as itraconazole, fluoxetine,&#x000a0;and&#x000a0;ritonavir)&#x000a0;may result in decreased or increased clearance of the dexamethasone, risking false positive or negative results, respectively.<xref ref-type="bibr" rid="article-20423.r42">[42]</xref><xref ref-type="bibr" rid="article-20423.r43">[43]</xref>&#x000a0;This error can be overcome by measuring serum dexamethasone levels simultaneously with serum cortisol levels. Most laboratories that conduct this test provide reference ranges based on dexamethasone dose and interval of blood drawn.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Improper urine collection: An inadequately collected urine sample for urinary-free cortisol&#x000a0;leads to diagnostic errors. For this reason, the urine sample should include testing for 24-hour urinary creatinine excretion in addition to cortisol.<xref ref-type="bibr" rid="article-20423.r43">[43]</xref><xref ref-type="bibr" rid="article-20423.r44">[44]</xref>&#x000a0;In adults&#x000a0;younger&#x000a0;than 50, the&#x000a0;24-hour urinary creatinine excretion is approximately 15 to 20 mg/kg/day/d&#x000a0;in&#x000a0;women and 20 to 25 mg/kg/day/d&#x000a0;in men. In&#x000a0;those&#x000a0;older than 50, there is a progressive decline in muscle mass; creatinine excretion can be as low as 10 mg/kg/d.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Others: Cyclic Cushing syndrome and glucocorticoid receptor polymorphisms are rare causes of false test results.<xref ref-type="bibr" rid="article-20423.r43">[43]</xref><xref ref-type="bibr" rid="article-20423.r44">[44]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20423.s6" sec-type="Results, Reporting, and Critical Findings&#x0000d;&#x0000a;">
        <title>Results, Reporting, and Critical Findings
</title>
        <p>
<bold>Low-Dose Dexamethasone Suppression Test</bold>
</p>
        <p>In either of the low-dose&#x000a0;dexamethasone&#x000a0;suppression&#x000a0;tests (overnight or 2-day), a serum cortisol level of&#x000a0;1.8 mcg/dL (50 nmol/L) is the recommended cut-off value that increases the&#x000a0;diagnostic&#x000a0;sensitivity of the test to approximately 95%.<xref ref-type="bibr" rid="article-20423.r5">[5]</xref>&#x000a0;However, at this cut-off value, the specificity of the 2-day test is superior compared to that of the overnight test (97%-100% vs 86%). A recent meta-analysis showed that abnormal and expected results for the 1 mg overnight test had positive and negative likelihood ratios of 11.6 and 0.09, respectively.<xref ref-type="bibr" rid="article-20423.r45">[45]</xref>&#x000a0;On the other hand, for the 2-day 2-mg test, abnormal and normal results had positive and negative likelihood ratios of 7.3 and 0.8, respectively. Serum cortisol levels under 1.8 mcg/dL suggest adequate hypothalamic-pituitary-adrenal axis suppression by dexamethasone and exclude Cushing syndrome. Levels greater than 1.8 mcg/dL should&#x000a0;be verified&#x000a0;with a second test (24-hour urinary-free cortisol or late-night salivary cortisol) before establishing a confirmed diagnosis of Cushing syndrome.<xref ref-type="bibr" rid="article-20423.r29">[29]</xref></p>
        <p>
<bold>High-Dose Dexamethasone Suppression Test</bold>
</p>
        <p>A reduction in urinary-free&#x000a0;cortisol or serum cortisol greater than 50% overnight during a 2-day high-dose&#x000a0;dexamethasone&#x000a0;suppression&#x000a0;test makes Cushing disease&#x000a0;the likely source of adrenocorticotropic&#x000a0;hormone-dependent&#x000a0;Cushing syndrome. At a cut-off value of 50% suppression, the high-dose&#x000a0;dexamethasone&#x000a0;suppression&#x000a0;test provides a sensitivity and specificity of 60% to 100%, respectively. Increasing the cut-off value to&#x000a0;greater than&#x000a0;90% cortisol suppression increases the specificity of diagnosing Cushing disease to almost 100%, albeit at a much-reduced sensitivity.<xref ref-type="bibr" rid="article-20423.r44">[44]</xref>&#x000a0;Because of this limitation, the high-dose&#x000a0;dexamethasone&#x000a0;suppression&#x000a0;test is not recommended unless the pituitary magnetic resonance&#x000a0;imaging and bilateral inferior petrosal venous sampling are either negative or logistically challenging. Even in this scenario, the high-dose&#x000a0;dexamethasone&#x000a0;suppression&#x000a0;test&#x000a0;is performed&#x000a0;with a corticotropin-releasing hormone stimulation test to enhance diagnostic accuracy.<xref ref-type="bibr" rid="article-20423.r46">[46]</xref></p>
        <p>
<bold>Intravenous Dexamethasone Suppression Test</bold>
</p>
        <p>Cushing syndrome&#x000a0;is diagnosed&#x000a0;if the day&#x000a0;2&#x000a0;serum cortisol level is greater than 20% of the baseline value or greater than 4.7 mcg/dL (130 nmol/L) with a sensitivity of 100% and specificity of 96%.<xref ref-type="bibr" rid="article-20423.r31">[31]</xref><xref ref-type="bibr" rid="article-20423.r32">[32]</xref>&#x000a0;In addition, in Cushing disease, unlike other causes of Cushing syndrome, the serum cortisol level at the end of the infusion on day&#x000a0;1&#x000a0;typically shows&#x000a0;greater&#x000a0;than 70% suppression from the baseline, followed by rebound hypercortisolism in 24 hours.<xref ref-type="bibr" rid="article-20423.r33">[33]</xref></p>
        <p>
<bold>Dexamethasone Suppressed Corticotropin-Releasing Hormone Test</bold>
</p>
        <p>Serum cortisol levels&#x000a0;greater than 1.4 mcg/dL (39 nmol/L) at 15 minutes suggest Cushing disease with a 90% to 100% sensitivity and 50% to 100% specificity.<xref ref-type="bibr" rid="article-20423.r34">[34]</xref><xref ref-type="bibr" rid="article-20423.r47">[47]</xref>&#x000a0;Raising the cut-off value to greater than 3.8 mcg/dL (87 nmol/L) increases the specificity to 100% at the cost of a slightly reduced sensitivity at 94%.<xref ref-type="bibr" rid="article-20423.r48">[48]</xref>&#x000a0;The cumbersomeness of this test limits its extensive application in the ambulatory setting.<xref ref-type="bibr" rid="article-20423.r49">[49]</xref></p>
      </sec>
      <sec id="article-20423.s7" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Iatrogenic hypercortisolism is the most common cause of Cushing syndrome. Recognizing it&#x000a0;before these individuals are subject to further diagnostic testing is crucial; instead, the focus should be on titrating down<bold>&#x000a0;</bold>or discontinuing, if feasible,&#x000a0;the prescribed steroid dosage.<xref ref-type="bibr" rid="article-20423.r50">[50]</xref>&#x000a0;The dexamethasone suppression test must be performed and interpreted in the light of the pretest probability based on a detailed history and thorough physical examination. In addition, clinicians should be mindful of diagnostic accuracy, limitations, and interfering factors associated with all tests.<xref ref-type="bibr" rid="article-20423.r51">[51]</xref>&#x000a0;In cases with high clinical suspicion of Cushing syndrome but equivocal or negative test results, repeat testing should occur in 3 to 6 months, as untreated hypercortisolemia has detrimental consequences.<xref ref-type="bibr" rid="article-20423.r52">[52]</xref></p>
      </sec>
      <sec id="article-20423.s8" sec-type="Quality Control and Lab Safety&#x0000d;&#x0000a;">
        <title>Quality Control and Lab Safety
</title>
        <p>For nonwaived tests, laboratory regulations require, at the minimum, analysis of at least 2 levels of control materials once every 24 hours. If necessary, laboratories can assay quality control (QC) samples more frequently to ensure accurate results.&#x000a0;QC samples should be assayed after calibration or maintenance of an analyzer to verify the correct method performance.<xref ref-type="bibr" rid="article-20423.r53">[53]</xref>&#x000a0;To minimize QC when performing tests for which manufacturers' recommendations are less than those required by the regulatory agency, such as once per month, the laboratories can develop an individualized quality control plan (IQCP) that involves performing a risk assessment of potential sources of error in all phases of testing and putting in place a QC plan to reduce the likelihood of errors.<xref ref-type="bibr" rid="article-20423.r54">[54]</xref></p>
        <p>Westgard multi-rules are used to evaluate the QC runs. If a run is declared out of control, the system, including instruments, standards, and controls, should be investigated to identify the underlying issue. Any analysis should not be performed until the problem has been resolved.<xref ref-type="bibr" rid="article-20423.r55">[55]</xref></p>
        <p>All specimens, control materials, and calibrator materials are considered potentially infectious. The standard precautions required for handling all laboratory reagents should be exercised. Disposal of all waste materials should be in accordance with local guidelines.<xref ref-type="bibr" rid="article-20423.r56">[56]</xref>&#x000a0;Gloves, a lab coat, and safety glasses should be worn when handling human blood specimens. All plastic tips, sample cups, and gloves that come into contact with blood should be placed in a biohazard waste container. All disposable glassware should be discarded into sharps waste containers.<xref ref-type="bibr" rid="article-20423.r57">[57]</xref>&#x000a0;All work surfaces should be protected with disposable absorbent bench top paper, which should be discarded into biohazard waste containers weekly or whenever blood contamination occurs. Finally, all work surfaces should be wiped weekly.<xref ref-type="bibr" rid="article-20423.r58">[58]</xref></p>
      </sec>
      <sec id="article-20423.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Primary care providers may initially evaluate patients with suspected Cushing syndrome before referring them to an endocrinologist for a more comprehensive evaluation. This collaborative approach requires clear communication and careful coordination between the clinician and patient. The accurate implementation of the dexamethasone suppression test and proper sample collection are critical aspects of this process, as they can significantly influence subsequent diagnostic results.</p>
        <p>Effective communication ensures that all stakeholders understand the importance of adhering to the testing protocol and the implications of accurate test performance. Coordination among the team members ensures that the dexamethasone suppression test is conducted correctly and that samples are collected and handled appropriately to minimize the risk of errors and ensure reliable results. This collaborative effort maximizes the diagnostic accuracy of the dexamethasone suppression test and facilitates the timely and appropriate management of patients with suspected Cushing syndrome.</p>
      </sec>
      <sec id="article-20423.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20423&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20423">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20423/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20423">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20423.s11">
        <fig id="article-20423.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Dexamethasone Suppression Test. The types and indications for dexamethasone suppression tests are illustrated. Contributed by P Dogra, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Dexamethasone__Suppression__Test" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20423.s12">
        <title>References</title>
        <ref id="article-20423.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keevil</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Improving the Dexamethasone Suppression Test.</article-title>
            <source>Clin Chem</source>
            <year>2021</year>
            <month>Jul</month>
            <day>06</day>
            <volume>67</volume>
            <issue>7</issue>
            <fpage>929</fpage>
            <page-range>929-931</page-range>
            <pub-id pub-id-type="pmid">34125167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LIDDLE</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1960</year>
            <month>Dec</month>
            <volume>20</volume>
            <fpage>1539</fpage>
            <page-range>1539-60</page-range>
            <pub-id pub-id-type="pmid">13761950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Clinical Pharmacology of Corticosteroids.</article-title>
            <source>Respir Care</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>655</fpage>
            <page-range>655-670</page-range>
            <pub-id pub-id-type="pmid">29794202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Toriumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Itoh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ogino</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>[Dexamethasone suppression test].</article-title>
            <source>Nihon Rinsho</source>
            <year>1997</year>
            <month>Apr</month>
            <volume>55 Suppl 2</volume>
            <fpage>353</fpage>
            <page-range>353-6</page-range>
            <pub-id pub-id-type="pmid">9172546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nieman</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Biller</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Findling</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Newell-Price</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Savage</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Montori</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2008</year>
            <month>May</month>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>1526</fpage>
            <page-range>1526-40</page-range>
            <pub-id pub-id-type="pmid">18334580</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fleseriu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Auchus</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bancos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ben-Shlomo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bertherat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Biermasz</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Boguszewski</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Bronstein</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Buchfelder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carmichael</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Casanueva</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Castinetti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chanson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Findling</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gadelha</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geer</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Giustina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gurnell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ioachimescu</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Kaiser</surname>
                <given-names>UB</given-names>
              </name>
              <name>
                <surname>Karavitaki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Katznelson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Lacroix</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McCormack</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Melmed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Molitch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mortini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Newell-Price</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nieman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Petersenn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pivonello</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Raff</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Reincke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salvatori</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Scaroni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shimon</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Swearingen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tabarin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Theodoropoulou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsagarakis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Valassi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Varlamov</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Vila</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wass</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Zatelli</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Biller</surname>
                <given-names>BMK</given-names>
              </name>
            </person-group>
            <article-title>Consensus on diagnosis and management of Cushing's disease: a guideline update.</article-title>
            <source>Lancet Diabetes Endocrinol</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>12</issue>
            <fpage>847</fpage>
            <page-range>847-875</page-range>
            <pub-id pub-id-type="pmid">34687601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farinelli</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Kater</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Overnight 1-mg Dexamethasone Suppression Test for Screening Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS): What Happens when Serum Dexamethasone Is Below Cutoff? How Frequent Is it?</article-title>
            <source>Endocr Pract</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>29</volume>
            <issue>12</issue>
            <fpage>986</fpage>
            <page-range>986-993</page-range>
            <pub-id pub-id-type="pmid">37734596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spencer</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Deak</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>A users guide to HPA axis research.</article-title>
            <source>Physiol Behav</source>
            <year>2017</year>
            <month>Sep</month>
            <day>01</day>
            <volume>178</volume>
            <fpage>43</fpage>
            <page-range>43-65</page-range>
            <pub-id pub-id-type="pmid">27871862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aguilera</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The molecular physiology of CRH neurons.</article-title>
            <source>Front Neuroendocrinol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-84</page-range>
            <pub-id pub-id-type="pmid">21871477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brownstein</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Adrenocorticotropic hormone (ACTH) in the central nervous system.</article-title>
            <source>Adv Biochem Psychopharmacol</source>
            <year>1980</year>
            <volume>22</volume>
            <fpage>93</fpage>
            <page-range>93-9</page-range>
            <pub-id pub-id-type="pmid">6249088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanaka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Cortisol].</article-title>
            <source>Nihon Rinsho</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>53 Su Pt 2</volume>
            <fpage>437</fpage>
            <page-range>437-40</page-range>
            <pub-id pub-id-type="pmid">8753275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hodes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lodish</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Zilbermint</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Mini-review of hair cortisol concentration for evaluation of Cushing syndrome.</article-title>
            <source>Expert Rev Endocrinol Metab</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>225</fpage>
            <page-range>225-231</page-range>
            <pub-id pub-id-type="pmid">30234410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sederberg-Olsen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Binder</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kehlet</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Urinary excretion of free cortisol in impaired renal function.</article-title>
            <source>Acta Endocrinol (Copenh)</source>
            <year>1975</year>
            <month>Jan</month>
            <volume>78</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-90</page-range>
            <pub-id pub-id-type="pmid">1172895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Billon-Rey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beylot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mathian</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Patricot</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Berthezene</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mornex</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Revol</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Comparison between the value of urinary free cortisol and 17-hydroxycorticosteroids for the diagnosis of Cushing's syndrome].</article-title>
            <source>Presse Med</source>
            <year>1986</year>
            <month>May</month>
            <day>24</day>
            <volume>15</volume>
            <issue>21</issue>
            <fpage>965</fpage>
            <page-range>965-8</page-range>
            <pub-id pub-id-type="pmid">2942852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mengden</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hubmann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Greminger</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vetter</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome.</article-title>
            <source>Clin Investig</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>70</volume>
            <issue>7</issue>
            <fpage>545</fpage>
            <page-range>545-8</page-range>
            <pub-id pub-id-type="pmid">1327327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Technical and clinical aspects of cortisol as a biochemical marker of chronic stress.</article-title>
            <source>BMB Rep</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>209</fpage>
            <page-range>209-16</page-range>
            <pub-id pub-id-type="pmid">25560699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lowrance</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ionadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McKay</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Sympathetic nervous system contributes to enhanced corticosterone levels following chronic stress.</article-title>
            <source>Psychoneuroendocrinology</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>68</volume>
            <fpage>163</fpage>
            <page-range>163-70</page-range>
            <pub-id pub-id-type="pmid">26974501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maidana</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>OD</given-names>
              </name>
              <name>
                <surname>Mesch</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>[A critical analysis of cortisol measurements: an update].</article-title>
            <source>Medicina (B Aires)</source>
            <year>2013</year>
            <volume>73</volume>
            <issue>6</issue>
            <fpage>579</fpage>
            <page-range>579-84</page-range>
            <pub-id pub-id-type="pmid">24356273</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gatti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Prearo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spinella</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cappellin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>De Palo</surname>
                <given-names>EF</given-names>
              </name>
            </person-group>
            <article-title>Cortisol assays and diagnostic laboratory procedures in human biological fluids.</article-title>
            <source>Clin Biochem</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>42</volume>
            <issue>12</issue>
            <fpage>1205</fpage>
            <page-range>1205-17</page-range>
            <pub-id pub-id-type="pmid">19414006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Farhan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rees</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Measuring cortisol in serum, urine and saliva - are our assays good enough?</article-title>
            <source>Ann Clin Biochem</source>
            <year>2017</year>
            <month>May</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>308</fpage>
            <page-range>308-322</page-range>
            <pub-id pub-id-type="pmid">28068807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turpeinen</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>H&#x000e4;m&#x000e4;l&#x000e4;inen</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Determination of cortisol in serum, saliva and urine.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>795</fpage>
            <page-range>795-801</page-range>
            <pub-id pub-id-type="pmid">24275191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Casals</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hanzu</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?</article-title>
            <source>Ann Lab Med</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>40</volume>
            <issue>4</issue>
            <fpage>285</fpage>
            <page-range>285-296</page-range>
            <pub-id pub-id-type="pmid">32067427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alwani</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Schmit Jongbloed</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>van der Lely</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>de Herder</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Feelders</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>170</volume>
            <issue>4</issue>
            <fpage>477</fpage>
            <page-range>477-86</page-range>
            <pub-id pub-id-type="pmid">24394725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mezzullo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fanelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fazzini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gambineri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vicennati</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Di Dalmazi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pelusi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mazza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pagotto</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Pasquali</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Validation of an LC-MS/MS salivary assay for glucocorticoid status assessment: Evaluation of the diurnal fluctuation of cortisol and cortisone and of their association within and between serum and saliva.</article-title>
            <source>J Steroid Biochem Mol Biol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>163</volume>
            <fpage>103</fpage>
            <page-range>103-12</page-range>
            <pub-id pub-id-type="pmid">27108942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hariharan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Naga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>VanNoord</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kindt</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <article-title>Simultaneous assay of corticosterone and cortisol in plasma by reversed-phase liquid chromatography.</article-title>
            <source>Clin Chem</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>346</fpage>
            <page-range>346-52</page-range>
            <pub-id pub-id-type="pmid">1547550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mezzullo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fazzini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gambineri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Di Dalmazi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mazza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pelusi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vicennati</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pasquali</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pagotto</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Fanelli</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Parallel diurnal fluctuation of testosterone, androstenedione, dehydroepiandrosterone and 17OHprogesterone as assessed in serum and saliva: validation of a novel liquid chromatography-tandem mass spectrometry method for salivary steroid profiling.</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2017</year>
            <month>Aug</month>
            <day>28</day>
            <volume>55</volume>
            <issue>9</issue>
            <fpage>1315</fpage>
            <page-range>1315-1323</page-range>
            <pub-id pub-id-type="pmid">28076306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wood</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Barth</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Freedman</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sheridan</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories.</article-title>
            <source>Ann Clin Biochem</source>
            <year>1997</year>
            <month>May</month>
            <volume>34 ( Pt 3)</volume>
            <fpage>222</fpage>
            <page-range>222-9</page-range>
            <pub-id pub-id-type="pmid">9158818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cronin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Igoe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Duffy</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>McKenna</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>The overnight dexamethasone test is a worthwhile screening procedure.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>1990</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-33</page-range>
            <pub-id pub-id-type="pmid">2401096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>NUGENT</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>NICHOLS</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>TYLER</surname>
                <given-names>FH</given-names>
              </name>
            </person-group>
            <article-title>DIAGNOSIS OF CUSHING'S SYNDROME; SINGLE DOSE DEXAMETHASONE SUPPRESSION TEST.</article-title>
            <source>Arch Intern Med</source>
            <year>1965</year>
            <month>Aug</month>
            <volume>116</volume>
            <fpage>172</fpage>
            <page-range>172-6</page-range>
            <pub-id pub-id-type="pmid">14315650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruno</surname>
                <given-names>OD</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Contreras</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Galparsoro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cazado</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kral</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leber</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Arias</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome.</article-title>
            <source>Acta Endocrinol (Copenh)</source>
            <year>1985</year>
            <month>Jun</month>
            <volume>109</volume>
            <issue>2</issue>
            <fpage>158</fpage>
            <page-range>158-62</page-range>
            <pub-id pub-id-type="pmid">2990131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biemond</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Lamberts</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Continuous dexamethasone infusion for seven hours in patients with the Cushing syndrome. A superior differential diagnostic test.</article-title>
            <source>Ann Intern Med</source>
            <year>1990</year>
            <month>May</month>
            <day>15</day>
            <volume>112</volume>
            <issue>10</issue>
            <fpage>738</fpage>
            <page-range>738-42</page-range>
            <pub-id pub-id-type="pmid">2158760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jung</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alford</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Topliss</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Burgess</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gome</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Stockigt</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Inder</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>73</volume>
            <issue>1</issue>
            <fpage>78</fpage>
            <page-range>78-84</page-range>
            <pub-id pub-id-type="pmid">20039897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tran</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Petrovsky</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Dexamethasone infusion testing in the diagnosis of Cushing's syndrome.</article-title>
            <source>Endocr J</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-9</page-range>
            <pub-id pub-id-type="pmid">15758565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yanovski</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Cutler</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Nieman</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.</article-title>
            <source>JAMA</source>
            <year>1993</year>
            <month>May</month>
            <day>05</day>
            <volume>269</volume>
            <issue>17</issue>
            <fpage>2232</fpage>
            <page-range>2232-8</page-range>
            <pub-id pub-id-type="pmid">8386285</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raff</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Cushing's syndrome: from physiological principles to diagnosis and clinical care.</article-title>
            <source>J Physiol</source>
            <year>2015</year>
            <month>Feb</month>
            <day>01</day>
            <volume>593</volume>
            <issue>3</issue>
            <fpage>493</fpage>
            <page-range>493-506</page-range>
            <pub-id pub-id-type="pmid">25480800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pektas</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Dogan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cinar</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Iatrogenic Cushing's Syndrome with Subsequent Adrenal Insufficiency in a Patient with Psoriasis Vulgaris Using Topical Steroids.</article-title>
            <source>Case Rep Endocrinol</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>8320254</fpage>
            <pub-id pub-id-type="pmid">29259830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bansal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>El Asmar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Selman</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Arafah</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Pitfalls in the diagnosis and management of Cushing's syndrome.</article-title>
            <source>Neurosurg Focus</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>E4</fpage>
            <pub-id pub-id-type="pmid">25639322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chabre</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").</article-title>
            <source>Ann Endocrinol (Paris)</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>138</fpage>
            <page-range>138-145</page-range>
            <pub-id pub-id-type="pmid">29716734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bae</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Kratzsch</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroid-binding globulin: modulating mechanisms of bioavailability of cortisol and its clinical implications.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>761</fpage>
            <page-range>761-72</page-range>
            <pub-id pub-id-type="pmid">26522460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stephens</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wand</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Stress and the HPA axis: role of glucocorticoids in alcohol dependence.</article-title>
            <source>Alcohol Res</source>
            <year>2012</year>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>468</fpage>
            <page-range>468-83</page-range>
            <pub-id pub-id-type="pmid">23584113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meikle</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>1982</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>401</fpage>
            <page-range>401-8</page-range>
            <pub-id pub-id-type="pmid">7094363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rush</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Schlesser</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Giles</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Crowley</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Fairchild</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Altshuler</surname>
                <given-names>KZ</given-names>
              </name>
            </person-group>
            <article-title>The effect of dosage on the dexamethasone suppression test in normal controls.</article-title>
            <source>Psychiatry Res</source>
            <year>1982</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>277</fpage>
            <page-range>277-85</page-range>
            <pub-id pub-id-type="pmid">6962436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meinardi</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Wolffenbuttel</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Dullaart</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Cyclic Cushing's syndrome: a clinical challenge.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>157</volume>
            <issue>3</issue>
            <fpage>245</fpage>
            <page-range>245-54</page-range>
            <pub-id pub-id-type="pmid">17766705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flack</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Oldfield</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Cutler</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Zweig</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Malley</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Loriaux</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Nieman</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome.</article-title>
            <source>Ann Intern Med</source>
            <year>1992</year>
            <month>Feb</month>
            <day>01</day>
            <volume>116</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-7</page-range>
            <pub-id pub-id-type="pmid">1728204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elamin</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Mullan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Erickson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nadeem</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ennis</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Montori</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2008</year>
            <month>May</month>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>1553</fpage>
            <page-range>1553-62</page-range>
            <pub-id pub-id-type="pmid">18334594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aron</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Raff</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Findling</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>82</volume>
            <issue>6</issue>
            <fpage>1780</fpage>
            <page-range>1780-5</page-range>
            <pub-id pub-id-type="pmid">9177382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pecori Giraldi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pivonello</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ambrogio</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>De Martino</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>De Martin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scacchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Colao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Toja</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cavagnini</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>66</volume>
            <issue>2</issue>
            <fpage>251</fpage>
            <page-range>251-7</page-range>
            <pub-id pub-id-type="pmid">17223996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tirabassi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Papa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Faloia</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Boscaro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arnaldi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and pseudo-Cushing state: a comparative study.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>75</volume>
            <issue>5</issue>
            <fpage>666</fpage>
            <page-range>666-72</page-range>
            <pub-id pub-id-type="pmid">21554373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Findling</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Raff</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome).</article-title>
            <source>Eur J Endocrinol</source>
            <year>2017</year>
            <month>May</month>
            <volume>176</volume>
            <issue>5</issue>
            <fpage>R205</fpage>
            <page-range>R205-R216</page-range>
            <pub-id pub-id-type="pmid">28179447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pivonello</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>De Martino</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>De Leo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Colao</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cushing's Syndrome.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>135</fpage>
            <page-range>135-49, ix</page-range>
            <pub-id pub-id-type="pmid">18226734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nieman</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Ilias</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Evaluation and treatment of Cushing's syndrome.</article-title>
            <source>Am J Med</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>118</volume>
            <issue>12</issue>
            <fpage>1340</fpage>
            <page-range>1340-6</page-range>
            <pub-id pub-id-type="pmid">16378774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nieman</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of Cushing's Syndrome in the Modern Era.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>47</volume>
            <issue>2</issue>
            <fpage>259</fpage>
            <page-range>259-273</page-range>
            <pub-id pub-id-type="pmid">29754631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poh</surname>
                <given-names>DKH</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>RZ</given-names>
              </name>
              <name>
                <surname>Markus</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Loh</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control: Moving average algorithms outperform Westgard rules.</article-title>
            <source>Clin Biochem</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>98</volume>
            <fpage>63</fpage>
            <page-range>63-69</page-range>
            <pub-id pub-id-type="pmid">34534518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kearney</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control.</article-title>
            <source>Methods Mol Biol</source>
            <year>2013</year>
            <volume>1065</volume>
            <fpage>277</fpage>
            <page-range>277-89</page-range>
            <pub-id pub-id-type="pmid">23996371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bayat</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Selecting multi-rule quality control procedures based on patient risk.</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2017</year>
            <month>Oct</month>
            <day>26</day>
            <volume>55</volume>
            <issue>11</issue>
            <fpage>1702</fpage>
            <page-range>1702-1708</page-range>
            <pub-id pub-id-type="pmid">28236626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cornish</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Arambula</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Arduino</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bryan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dickson</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Giri</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Pentella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Salerno</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Sandhu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Snyder</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Tormey</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Wagar</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Weirich</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2021</year>
            <month>Jun</month>
            <day>16</day>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>e0012618</fpage>
            <pub-id pub-id-type="pmid">34105993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bowles</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Dern</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Podzorski</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Bateman</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Block</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Kropp</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Radke</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Siebers</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Simmons</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Spray-Larson</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Warshauer</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Laboratory Focus on Improving the Culture of Biosafety: Statewide Risk Assessment of Clinical Laboratories That Process Specimens for Microbiologic Analysis.</article-title>
            <source>J Clin Microbiol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>56</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">29118166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20423.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ionescu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Negu&#x00163;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Combiescu</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>[Biosafety and biosecurity in the medical laboratory. Update and trends].</article-title>
            <source>Bacteriol Virusol Parazitol Epidemiol</source>
            <year>2007</year>
            <season>Jul-Dec</season>
            <volume>52</volume>
            <issue>3-4</issue>
            <fpage>91</fpage>
            <page-range>91-9</page-range>
            <pub-id pub-id-type="pmid">19326721</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
